
Digitalis Ventures
11 Times Square, Suite 1500A, New York, NY, 10036, United States
Overview
Venture capital firm investing in human and animal health solutions.
Founded
2016
Deals ยท 12mo
11
Stage focus
Geographic focus
Sector focus
Investment portfolio
| NAME | DATE | SIZE | |
|---|---|---|---|
Matchpoint Therapeutics | Oct 2026Participated | $150 MSeries B | |
Enveda Biosciences | Sep 2026Participated | $311 MSeries E | |
Buddy Bites | Aug 2026Led | $4 MSeries A | |
Omni | Jun 2026Participated | $15 MOther Equity | |
Neion Bio | Jun 2026Participated | $23 MSeries A | |
Travv | May 2026Led | $2 MSeed | |
Clasp | Mar 2026Led | $20 MSeries B | |
EpiBiologics | Jan 2026Participated | $107 MSeries B | |
Protego Biopharma | Dec 2025Participated | $130 MSeries B | |
T-Therapeutics | Nov 2025Participated | $32 MSeries A | |
Faeth Therapeutics | Oct 2025Participated | $25 MOther Equity | |
Positive Development | Aug 2025Participated | $52 MSeries C | |
Matchpoint Therapeutics | Oct 2026Participated | $150 MSeries B | |
Enveda Biosciences | Sep 2026Participated | $311 MSeries E | |
Buddy Bites | Aug 2026Led | $4 MSeries A | |
Omni | Jun 2026Participated | $15 MOther Equity | |
Neion Bio | Jun 2026Participated | $23 MSeries A | |
Travv | May 2026Led | $2 MSeed | |
Clasp | Mar 2026Led | $20 MSeries B | |
EpiBiologics | Jan 2026Participated | $107 MSeries B | |
Protego Biopharma | Dec 2025Participated | $130 MSeries B | |
T-Therapeutics | Nov 2025Participated | $32 MSeries A | |
Faeth Therapeutics | Oct 2025Participated | $25 MOther Equity | |
Positive Development | Aug 2025Participated | $52 MSeries C |
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Seed | 3 | 3 |
| Series A | 4 | 18 |
| Series B | 4 | 16 |
| Series C+ | 0 | 5 |
| Other Equity | 0 | 8 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Apr '16 | 1 |
| May '16 | 0 |
| Jun '16 | 0 |
| Jul '16 | 1 |
| Aug '16 | 0 |
| Sep '16 | 0 |
| Oct '16 | 0 |
| Nov '16 | 0 |
| Dec '16 | 0 |
| Jan '17 | 0 |
| Feb '17 | 0 |
| Mar '17 | 1 |
| Apr '17 | 0 |
| May '17 | 0 |
| Jun '17 | 0 |
| Jul '17 | 0 |
| Aug '17 | 1 |
| Sep '17 | 1 |
| Oct '17 | 0 |
| Nov '17 | 0 |
| Dec '17 | 0 |
| Jan '18 | 0 |
| Feb '18 | 0 |
| Mar '18 | 0 |
| Apr '18 | 0 |
| May '18 | 0 |
| Jun '18 | 0 |
| Jul '18 | 0 |
| Aug '18 | 0 |
| Sep '18 | 0 |
| Oct '18 | 0 |
| Nov '18 | 0 |
| Dec '18 | 0 |
| Jan '19 | 0 |
| Feb '19 | 0 |
| Mar '19 | 1 |
| Apr '19 | 1 |
| May '19 | 0 |
| Jun '19 | 1 |
| Jul '19 | 0 |
| Aug '19 | 0 |
| Sep '19 | 0 |
| Oct '19 | 0 |
| Nov '19 | 0 |
| Dec '19 | 0 |
| Jan '20 | 0 |
| Feb '20 | 0 |
| Mar '20 | 0 |
| Apr '20 | 0 |
| May '20 | 1 |
| Jun '20 | 0 |
| Jul '20 | 0 |
| Aug '20 | 0 |
| Sep '20 | 0 |
| Oct '20 | 0 |
| Nov '20 | 0 |
| Dec '20 | 1 |
| Jan '21 | 0 |
| Feb '21 | 0 |
| Mar '21 | 0 |
| Apr '21 | 1 |
| May '21 | 1 |
| Jun '21 | 1 |
| Jul '21 | 0 |
| Aug '21 | 2 |
| Sep '21 | 2 |
| Oct '21 | 1 |
| Nov '21 | 1 |
| Dec '21 | 1 |
| Jan '22 | 0 |
| Feb '22 | 1 |
| Mar '22 | 1 |
| Apr '22 | 0 |
| May '22 | 1 |
| Jun '22 | 0 |
| Jul '22 | 0 |
| Aug '22 | 0 |
| Sep '22 | 0 |
| Oct '22 | 1 |
| Nov '22 | 2 |
| Dec '22 | 0 |
| Jan '23 | 1 |
| Feb '23 | 0 |
| Mar '23 | 2 |
| Apr '23 | 1 |
| May '23 | 1 |
| Jun '23 | 0 |
| Jul '23 | 1 |
| Aug '23 | 0 |
| Sep '23 | 0 |
| Oct '23 | 1 |
| Nov '23 | 1 |
| Dec '23 | 0 |
| Jan '24 | 2 |
| Feb '24 | 0 |
| Mar '24 | 1 |
| Apr '24 | 1 |
| May '24 | 2 |
| Jun '24 | 0 |
| Jul '24 | 2 |
| Aug '24 | 0 |
| Sep '24 | 0 |
| Oct '24 | 2 |
| Nov '24 | 0 |
| Dec '24 | 1 |
| Jan '25 | 1 |
| Feb '25 | 0 |
| Mar '25 | 1 |
| Apr '25 | 0 |
| May '25 | 0 |
| Jun '25 | 1 |
| Jul '25 | 1 |
| Aug '25 | 1 |
| Sep '25 | 0 |
| Oct '25 | 1 |
| Nov '25 | 1 |
| Dec '25 | 1 |
| Jan '26 | 1 |
| Feb '26 | 0 |
| Mar '26 | 1 |
| Apr '26 | 0 |
| May '26 | 1 |
| Jun '26 | 2 |
| Jul '26 | 0 |
| Aug '26 | 1 |
| Sep '26 | 1 |
| Oct '26 | 1 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 47 |
| Consumer & Lifestyle | 7 |
| AI & Machine Learning | 7 |
| Networks, Cloud & Communication | 5 |
| Fintech | 4 |
| Professional Services | 4 |
| Education & Workforce | 3 |
| Enterprise Software | 3 |
| Data, Analytics & IT | 3 |
| Food & Agriculture | 3 |
| Government & Defense | 2 |
| E-Commerce & Retail | 2 |
| Marketing & Advertising | 2 |
| Transportation & Logistics | 1 |
| Hardware & Robotics | 1 |
| Manufacturing | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 4 |
| $5M-$10M | 10 |
| $10M-$25M | 16 |
| $25M-$50M | 13 |
| $50M-$100M | 7 |
| $100M-$250M | 9 |
| $250M-$500M | 2 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 6 of 6 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| United States | 50 |
| Europe | 7 |
| China | 1 |
| Australia | 1 |
| Hong Kong | 1 |
| V5t 1m4 | 1 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| Alexandria Venture Investments | 6 |
| KdT Ventures | 6 |
| RiverVest Venture Partners | 6 |
| Roche Venture | 5 |
| Sanofi Ventures | 5 |
| Bold Capital Partners | 4 |
| Codon Capital | 4 |
| F-Prime Capital | 4 |
| Owl Rock | 4 |
| Two Sigma Ventures | 4 |
| 3x5 Partners | 3 |
| abrdn | 3 |
| B Capital Group | 3 |
| Cambridge Innovation Capital | 3 |
| Flare Capital Partners | 3 |
| Innovation Endeavors | 3 |
| Invus | 3 |
| Leaps by Bayer | 3 |
| Lightspeed Venture Partners | 3 |
| Mission BioCapital | 3 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 11 | 18% |
| Participating | 50 | 82% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 6 | 55% |
| Co-led | 5 | 45% |
Team
Partner
Co-Founder
Partner
Technical Partner
Partner
founder and managing partner
Principal
Managing Partner
Partner
Partner